Brief: Telcon Rf Pharmaceutical To Conduct Capital Increase Of 28 Billion Won
23/05/2025 09:22
Telcon RF Pharmaceutical Inc 200230.KQ: TELCON RF PHARMACEUTICAL: TO CONDUCT CAPITAL INCREASE OF 28 BILLION WON Source text: [ID:] Further company coverage: 200230.KQ
Recent news on Telcon RF Pharmaceutical
See all newsBrief: Telcon Rf Pharmaceutical To Conduct Capital Increase Of 28 Billion Won
Brief: Telcon Rf Pharmaceutical Inc To Acquire 10 Billion Won Worth Of Shares In Abion Inc
Brief: Telcon Rf Pharmaceutical To Acquire 16 Billion Won Worth Of Shares In Abion Inc
Brief: Humanigen Executes Licensing Agreement For Lenzilumab In Covid-19 With KPM Tech/Telcon RF Pharmaceutical For South Korea And The Philippines
Brief: Emmaus Life Sciences Announces The Sale Of Its Telcon Rf Pharmaceutical Inc. Shares